Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks.
Weber DG, Casjens S, Rozynek P, Lehnert M, Zilch-Schöneweis S, Bryk O, Taeger D, Gomolka M, Kreuzer M, Otten H, Pesch B, Johnen G, Brüning T
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of stabilization of RNA in blood with PAXgene or RNAlater during shipping and frozen storage. Peripheral blood was collected from former uranium miners in an EDTA vacutainer, aliquoted, and mixed with RNAlater, or blood was collected directly into PAXgene tubes. RNA was extracted from PAXgene specimens using the PAXgene kit, but RNA was extracted from RNAlater-preserved specimens using the RiboPure blood kit.
Summary of Findings
The RNA integrity and yield were higher from the RNAlater-preserved specimens than from the PAXgene-preserved specimens (p<0.0001), and RNA yield was higher from specimens shipped on dry ice than those shipped at ambient temperatures (p<0.0001). The highest RNA yield and integrity were observed in RNAlater specimens shipped on dry ice and then extracted immediately or stored frozen for 6 months. The lowest RNA yield and integrity were observed in PAXgene specimens shipped at ambient temperatures. Frozen and stored PAXgene-preserved specimens had higher RNA yields than frozen specimens not treated with either PAXgene or RNAlater (2.2 ug/mL versus 1.6 ug/mL; p=0.0002). A slight reduction in RNA yield and integrity were observed in PAXgene specimens shipped at ambient temperature for 4 days compared to 1-2 days, but a similar decrease was not observed in RNAlater-preserved specimens, and there were not enough specimens to determine statistical significance. Relative to GAPDH levels, levels of ATM and miRNA26b transcripts were generally not affected by preservation system or shipping conditions, but significantly more ATM was detected in RNAlater specimens that were shipped on dry ice and stored frozen for 6 months than those shipped frozen and not stored (p<0.0001), and more miRNA26b was detected in PAXgene specimens shipped at ambient temperatures rather than on dry ice (p<0.0001) and in RNAlater, rather than PAXgene-preserved specimens, shipped on dry ice and stored frozen (p<0.0001). In contrast, relative miRNA26a levels were higher in unstored RNAlater-preserved specimens than in PAXgene-preserved specimens (both shipping conditions, p<0.0001) and after frozen storage compared to specimens processed immediately (both preservation systems, p<0.0001).
Biospecimens
FluidBloodPreservation Types
RNAlaterPAXgeneDiagnoses
Not specifiedPlatforms
RNAAutomated electrophoresis/BioanalyzerRNAReal-time qRT-PCRRNASpectrophotometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation PAXgeneRNAlaterStorage Between site transportation method CourierMailedStorage Specimen transport duration/condition 1-2 days4 daysAt ambient temperatureOn dry iceOvernightStorage Storage duration 0 days6 monthsAnalyte Extraction and Purification Analyte isolation method PAXgene blood kitRiboPure blood kitReal-time qRT-PCR Specific Targeted nucleic acid ATMGAPDHmiRNA26amiRNA26b